Sales Effectiveness

Skin cancer is often overlooked by many Americans, who are at elevated risk for being over exposed to the sun in the summer months.

The industry is facing challenges from the new administration that could have serious impacts on everything from market access, pricing, and supply chains.

In today’s environment, aligning the Target Product Profile with the appropriate Value Evidence Archetype is not just good practice, it is a strategic imperative.

A Harvard Business School Healthcare Alumni Association Q&A with Aileen Fernandes, Chief Business Officer of Arcellx.

In this Pharmaceutical Executive exclusive, Bob Jansen, David Shulkin, Gen. Paul Funk (Ret.), and Maj. Gen. Dennis LeMaster (Ret.)—members of the Federated Healthcare Advisory Panel—discuss how pharmaceutical companies can strengthen supply chain resilience, navigate policy shifts, and adopt a national security mindset.

The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children are vaccinated against all strains.

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively with the right message.

Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.

The window of opportunity for launch is short and unforgiving, and the success depends on flawless execution of launch activity across countries and functions.

Meeting the growing need and demand for fast information to make optimal and timely treatment decisions.

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average brands.

Navigating technology and regulatory shifts in pharma revenue management.

Five steps for organizations in bringing enterprise-level strategies to life.

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and profitability.

Ted Sweetser discusses turning information into usable datasets and pulling insights from them.

Sonam Dubey, a partner at Beghou Consulting, discusses the potential impact of a possible ban on direct-to-consumer advertising amid policy and government agency overhauls in the US.

The campaign is launching alongside positive news for the company’s Phase 3 trials for a GBS treatment.

Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.

Marketing and sales personnel who leverage the expertise and insights of MedAffairs can often have better success.

Addressing key challenges in the modern sales sector requires a fundamental shift in training strategies.

The high-stakes nature of cancer care, coupled with rapid scientific advancements and increasing payer and regulatory pressures, demands a specialized approach beyond traditional market access strategies.

Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, explores practical steps pharmaceutical executives can take to foster better collaboration within their organizations, as well as with external partners like providers and pharmacies.

Applying the McKinsey 7S Framework to TLL and regional marketing teams.

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic portfolio management to optimize resource allocation and enhance competitive advantage.

Market dynamics boost the need and urgency for more sophisticated benchmarking strategies.